Table 1.
Characteristics and clinicopathological features of the patients with pancreatic cyst
| Patient characteristics | IPMN (n = 27) | MCN (n = 13) | Others (n = 11) | Pseudocysts (n = 9) | Serous cystadenoma (n = 9) | |||
|---|---|---|---|---|---|---|---|---|
| Types of cysts (%) (n = 69) | Main branch IPMN | 2.9% | No definite clinical diagnosis (others) | 6.0% | ||||
| Mixed type IPMN | 5.8% | NET (others) | 3.0% | |||||
| Multifocal side branch IPMN | 5.8% | Acinar cell carcinoma (others) | 1.0% | |||||
| Side branch IPMN | 17.0% | Simple cyst (others) | 3.0% | |||||
| IPMN | 7.2% | Cystic GIST; no communication PD (others) | 3.0% | |||||
| Total percentage of samples in each pancreatic cyst | 39.10% | 18.8% | 15.90% | 13.0% | 13.0% | |||
| Resected sample percentage | 11.6% | 13% | 4.3% | 2.9% | 0.0% | |||
| Dysplasia | No Dysplasia | 66.7% | 53.8% | 100% | 100% | 100% | ||
| Adenoma | 11.1% | 38.5% | 0.0% | 0.0% | 0.0% | |||
| Moderate dysplasia | 11.1% | 7.7% | 0.0% | 0.0% | 0.0% | |||
| Carcinoma in situ | 11.1% | 0.0% | 0.0% | 0.0% | 0.0% | |||
| Gender | Male | 15.9% | 0.0% | 7.2% | 7.2% | 2.9% | ||
| Female | 21.7% | 17.4% | 7.2% | 5.8% | 10.1% | |||
| Not available | 1.4% | 1.4% | 1.4% | 0.0% | 0.0% | |||
| Average age | 68 years 11 months 22 days | 53 years 7 months 14 days | 62 years 5 months 14 days | 54 years 8 months 19 days | 59 years 9 months 18 days | |||